TABLE 2.
Antifungal resistance results of the clinical C. auris yeastsa
| Antifungal agent | No. of susceptible isolates | No. of S-DD isolates | No. of isolates that were resistant or NS (no. of patients) |
|---|---|---|---|
| Anidulafungin | 21 | 0 | 2 (1) |
| Micafungin | 21 | 0 | 2 (1) |
| Caspofungin | 21 | 0 | 2 (1) |
| 5-Flucytosine | 23 | 0 | 0 |
| Posaconazole | 23 | 0 | 0 |
| Voriconazole | 19 | 4 | 0 |
| Itraconazole | 5 | 18 | 0 |
| Fluconazole | 0 | 0 | 23 (15) |
| Amphotericin B | 5 | 0 | 18 (11) |
a
Twenty-three isolates were tested. The assays were conducted by using the Sensititre YeastOne panel according to the manufacturer's instructions (Trek Diagnostic System, Independence, OH). S-DD, susceptible-dose dependent; NS, nonsusceptible.